1057 studies found for:    Open Studies | "Acquired Immunodeficiency Syndrome"
Show Display Options
Rank Status Study
21 Unknown  Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma
Conditions: HIV;   Burkitt's Lymphoma
Interventions: Drug: Induction Phase;   Drug: Consolidation Phase (on day +50);   Drug: Intensification phase;   Drug: BEAM conditioning;   Radiation: Consolidation radiotherapy
22 Unknown  Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border
Condition: HIV Positive
Intervention:
23 Unknown  HIV-HBV Co-Infection and Liver Disease
Conditions: HIV Infections;   HIV-HBV Co-Infection
Intervention:
24 Recruiting Assessment of Age-related Hearing Loss in HIV-1 Patients
Condition: HIV Seropositivity
Intervention:
25 Recruiting HIV Non-Occupational Post-Exposure Prophylaxis
Condition: Human Immunodeficiency Virus
Intervention: Drug: Coformulated Elivitegravir (150mg), Combicistat (150mg), Emtricitabine (200mg), Tenofovir DF (300mg)
26 Not yet recruiting Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study
Conditions: HIV;   Human Immunodeficiency Virus
Intervention: Drug: Euphorbia kansui extract powder prepared as tea
27 Unknown  HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)
Condition: HIV Infections
Interventions: Drug: Pioglitazone;   Other: Observation
28 Unknown  Development of Resistance Mutations in Pregnant HIV-Positive (+) Women Following Perinatal Antiretroviral Therapy in Israel
Condition: HIV Infections
Intervention:
29 Recruiting Observational Study of HIV-associated Neurocognitive Disorder
Conditions: HIV Associated Neurocognitive Disorder;   Human Immunodeficiency Virus
Intervention:
30 Unknown  Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART)
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 2;   Drug: Placebo
31 Unknown  Early Identification and Treatment of Early HIV Infection in Côte d'Ivoire
Condition: HIV Infection
Intervention:
32 Unknown  Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV Patients
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 1;   Drug: Placebo
33 Recruiting Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted Darunavir
Condition: Acquired Immune Deficiency Syndrome Virus
Interventions: Drug: Dolutegravir;   Drug: Darunavir/r
34 Not yet recruiting HIV Drug Switch Followed by HCV Therapy in HIV-HCV Co-Infection
Conditions: Human Immunodeficiency Virus;   Hepatitis C, Chronic
Interventions: Drug: E/C/F/TAF;;   Drug: Ledipasvir-Sofosbuvir
35 Recruiting Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node Fibrosis
Conditions: Acute HIV Infection;   HIV CNS Involvement
Interventions: Drug: TDF/3TC/EFV + Telmisartan;   Drug: TDF/3TC/EFV only
36 Recruiting A Long-term Follow-up of the HIV-NAT Cohort
Condition: HIV Infections
Intervention:
37 Unknown  The Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS Patients
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 3;   Drug: Fuzheng 1;   Drug: Placebo
38 Recruiting Prospective Evaluation of HIV Patients Using Non-invasive Methods for Estimation of Liver Fibrosis and Steatosis
Conditions: Human Immunodeficiency Virus;   Acquired Immune Deficiency Syndrome Virus;   Liver Diseases;   Liver Cirrhosis;   Fibrosis
Intervention:
39 Recruiting Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV
Condition: Human Immunodeficiency Virus
Interventions: Drug: emtricitabine/tenofovir;   Behavioral: CBT-based counseling
40 Not yet recruiting A Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + Patients
Condition: Malaria in Pregnant HIV + Patients
Interventions: Drug: Mefloquine;   Drug: Sulphadoxine-Pyrimethamine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years